Drug
Disc 3405
Disc 3405: highest development phase Phase 1, developed by Disc Medicine, Inc. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Disc Medicine, Inc
Trials
| Drug | Phase | Indication |
|---|---|---|
| DISC-3405 NCT07187973 | Phase 1 | Sickle Cell Disease |
Latest
No recent events.
Follow Disc 3405 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.